Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

121.99
Delayed Data
As of Sep 21
 -2.62 / -2.10%
Today’s Change
102.10
Today|||52-Week Range
144.91
+2.01%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Hantson Ludwig N
Chief Executive Officer
Sale2/08/201813,245$116.31$1.5M+12.46%
Coughlin Christopher J
Director
Buy4/30/201810,000$120.79$1.2M+3.71%
Coughlin Christopher J
Director
Gift12/05/201710,000$112.75$1.1M+12.02%
Clancy Paul J
Chief Financial Officer & Executive Vice President
Sale2/08/20186,079$116.31$707.0K+12.46%
Clancy Paul J
Chief Financial Officer & Executive Vice President
Sale7/10/20185,241$131.11$687.1K-7.52%
Oneill Julie /alexion/
Sale2/08/20184,787$116.31$556.8K+12.46%
Hantson Ludwig N
Chief Executive Officer
Sale1/02/20182,553$121.63$310.5K-1.66%
Orloff John J
EVP-Research & Development
Sale6/08/20182,115$118.53$250.7K+3.09%
Moriarty John B Jr
General Counsel & Executive Vice President
Sale2/08/20182,163$115.70$250.3K+12.46%
Oneill Julie /alexion/
Sale2/05/20182,119$117.26$248.5K+8.22%
Page of 6